Pain
From the Journals
Fremanezumab may be an effective episodic migraine treatment
The CGRP monoclonal antibody fremanezumab significantly reduced the mean number of migraine days in patients with episodic migraine.
Conference Coverage
Multiple analgesia options for kids with acute pain
TORONTO – When analgesia is indicated, clinicians can choose from a variety of agents in the postcodeine era.
Daily News Podcast
MDedge Daily News: How to handle opioid constipation
And there may be a new option for postpartum depression.
Conference Coverage
Constipation on opioids? Follow these three steps to ID the true cause
LAS VEGAS – Treatment will depend on whether the patient had constipation before taking opioids.
Commentary
Pain: What We Have Achieved in the Past 25 Years
Dr. Ashina is Clinical Associate Professor, Department of Neurology, and Director of the Headache Center at NYU Langone Medical Center, New York,...
Conference Coverage
Cluster headache presents differently in never-smokers, survey finds
LOS ANGELES – Patients not exposed to tobacco developed cluster headache at a younger age than exposed subjects.
Conference Coverage
VIDEO: Eptinezumab shows efficacy in episodic and chronic migraine trials
LOS ANGELES – One-third of patients on a high dose of the novel CGRP-blocking monoclonal antibody saw migraines reduced by 75%.
Daily News Podcast
MDedge Daily News: Lupus is quietly killing young women
And does substance abuse trigger schizophrenia?
Conference Coverage
Beware nonopiate meds with high street value
NEW ORLEANS – Use these safeguards when prescribing gabapentin and other high-abuse-potential drugs.
Daily News Podcast
MDedge Daily News: Which nonopioids are ripe for abuse?
And bum kidneys shouldn’t stop dabigatran reversal.
Conference Coverage
Endometriosis pain stemming from pelvic spasms improved with botulinum toxin
LOS ANGELES - In a study enrolling 28 women with endometriosis, all had evidence of myofascial dysfunction and pain.